Oscar Health (NYSE:OSCR) Shares Down 6.3%

Oscar Health, Inc. (NYSE:OSCR) dropped 6.3% during mid-day trading on Friday . The stock traded as low as $16.17 and last traded at $16.54. Approximately 824,741 shares changed hands during trading, a decline of 75% from the average daily volume of 3,278,018 shares. The stock had previously closed at $17.65.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, May 9th. Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Raymond James started coverage on Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target for the company. Bank of America reaffirmed a “neutral” rating and set a $21.00 target price (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Finally, Robert W. Baird began coverage on Oscar Health in a research report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.

Oscar Health Stock Performance

The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $3.75 billion, a PE ratio of -39.55 and a beta of 1.68. The firm’s fifty day moving average price is $19.49 and its 200 day moving average price is $15.37.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The firm had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same quarter in the previous year, the company posted ($0.18) earnings per share. The business’s quarterly revenue was up 45.8% compared to the same quarter last year. On average, research analysts anticipate that Oscar Health, Inc. will post -0.05 earnings per share for the current year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 5,808 shares of Oscar Health stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $113,023.68. Following the completion of the sale, the insider now directly owns 65,920 shares in the company, valued at $1,282,803.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $362,092.22. Following the completion of the sale, the chief operating officer now owns 65,316 shares in the company, valued at approximately $1,271,049.36. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 5,808 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $113,023.68. Following the completion of the transaction, the insider now directly owns 65,920 shares in the company, valued at $1,282,803.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 81,655 shares of company stock worth $1,589,006. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Avalon Trust Co bought a new stake in shares of Oscar Health during the 1st quarter worth $69,000. Prevail Innovative Wealth Advisors LLC bought a new position in shares of Oscar Health in the fourth quarter worth about $92,000. Handelsbanken Fonder AB acquired a new position in shares of Oscar Health during the 4th quarter worth about $110,000. Focus Financial Network Inc. ADV bought a new stake in Oscar Health during the 4th quarter valued at approximately $152,000. Finally, Farallon Capital Management LLC acquired a new stake in Oscar Health in the 1st quarter valued at approximately $164,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.